Translational Advances in Cancer Prevention Agent Development

Meeting Objectives

The main goals of this meeting are to:

1. Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research,
2. Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and
3. Highlight the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.

Registration

Registration is free and required for meeting attendance.  The deadline to register for this event was August 17, 2020.

Agenda

Download the Agenda (PDF, 232 KB)

Meeting Organizers' Contact Information

Mark Steven Miller, Ph.D. Program Director National Cancer Institute Email: mark.miller5@nih.gov Phone: 240-276-5004 Altaf Mohammed, Ph.D. Program Director National Cancer Institute Email: altaf.mohammed@nih.gov Phone: 240-276-6082

More information: https://prevention.cancer.gov/news-and-events/meetings-and-events/translational-advances